文献速递冠心病

系列血小板功能检测对复杂PCI术后结局的预测价值

[Predictive value of serial platelet function testing on outcome in patients undergoing complex percutaneous coronary intervention].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2017-01-01

该回顾性研究纳入602例接受复杂PCI的冠心病患者,在术后第1、6、12个月用透光率比浊法检测ADP诱导的血小板聚集并计算均值,以≥40%定义HTPR。565例完成随访(28.47±7.45)个月,HTPR组MACCE发生率8.42%高于非HTPR组3.21%,HTPR是MACCE独立危险因素(HR=2.69,95%CI 1.23-5.85,P=0.01)。

要点

  • 复杂PCI术后系列血小板功能检测可预测长期MACCE风险。
  • ADP诱导平均血小板聚集度≥40%定义为HTPR。
  • HTPR患者MACCE风险升高,HR=2.69(95%CI 1.23-5.85)。

核心结论

  • 系列血小板功能检测能够预测复杂PCI术后患者的临床结局。

研究设计与样本

  • 回顾性分析2011年10月至2012年6月北京安贞医院602例接受复杂PCI的冠心病患者。
  • PCI术后第1、6、12个月用透光率比浊法检测ADP诱导血小板聚集并计算平均值。

主要发现

  • 565例完成随访,随访时间(28.47±7.45)个月,HTPR组285例、非HTPR组280例。
  • 随访期间共33例MACCE,HTPR组29例(8.42%),非HTPR组9例(3.21%)。
  • Kaplan-Meier分析显示HTPR组MACCE发生率高于非HTPR组(log-rank检验,P=0.01)。
  • Cox多因素分析显示HTPR是MACCE独立危险因素(HR=2.69,95%CI 1.23-5.85,P=0.01)。
  • HTPR患者接受标准DAPT与延长DAPT(>12个月)的MACCE发生率差异无统计学意义(P>0.05)。

关键数值与推荐

  • HTPR定义为ADP诱导的平均血小板聚集度≥40%。
  • 主要终点为MACCE。

临床怎么用

  • 对复杂PCI术后患者可考虑系列血小板功能检测以识别HTPR并评估长期MACCE风险。

局限性

  • 该研究为单中心回顾性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To observe the predictive value of serial platelet function testing (PFT) on outcome in patients undergoing complex percutaneous coronary intervention (PCI). Methods: Six hundred and two consecutive patients undergoing complex PCI in Anzhen hospital were enrolled during October 2011 to June 2012.Adenosine diphosphate(ADP)-induced platelet aggregation was measured by light transmission aggregometry on the first, sixth and twelfth month after PCI and the mean value was calculated.The cut-off value of high on-treatment platelet reactivity (HTPR) was defined as 40%.The primary endpoint was major adverse cardiovascular and cerebral event (MACCE). Clinical outcomes were analyzed by the Kaplan-Meier method and differences were compared using the log-rank test.Multivariate analyses by Cox proportion hazards regression were applied to identify variables independently associated with the adverse outcomes. Results: Five hundred and eighty-five patients (HTPR, n=285; non-HTPR, n=280) finished the follow-up ((28.47±7.45) months). A total of 33 cases of MACCE were observed during the follow-up, among which 29 cases(8.42%) were in HTPR group and 9 cases (3.21%) in the non-HTPR group.Kaplan-Meier analysis suggested that HTPR was associated with an increased incidence of MACCE (log-rank test, P=0.01). The Cox multivariate analysis indicated that HTPR was an independent risk factor of MACCE (HR=2.69, 95%CI 1.23-5.85, P=0.01) in patients undergoing complex PCI.Incidence of MACCE was similar between HTRP patients receiving standard dual antiplatelet therapy (DAPT) or prolonged DAPT (>12 months). Conclusion: Serial PFT could predict the long-term prognosis of patients underwent complex PCI. 目的: 评价血小板功能检测(PFT)对复杂经皮冠状动脉介入(PCI)术后患者临床结局的预测价值。 方法: 回顾性分析2011年10月至2012年6月于北京安贞医院接受复杂PCI治疗的602例冠心病患者,分别在PCI术后的第1、6和12个月使用透光率比浊法检测血小板功能,并计算其平均值,治疗期间高血小板活性(HTPR)定义为二磷酸腺苷(ADP)诱导的平均血小板聚集度≥40%。受试者根据平均ADP聚集度分为HTPR组(ADP≥40%)和非HTPR组(ADP<40%),并进一步将HTPR组患者分为标准双联抗血小板治疗(DAPT)及延长DAPT亚组。随访观察患者主要不良心脑血管事件(MACCE)发生率。采用Kaplan-Meier分析比较两组间MACCE发生率,使用Cox比例风险模型分析发生MACCE的影响因素。 结果: 共565例患者完成了随访,随访时间为(28.47±7.45)个月,HTPR组患者285例,非HTPR组患者280例。随访期间共发生33例MACCE,其中HTPR组29例(8.42%),非HTPR组9例(3.21%)。Kaplan-Meier分析显示HTPR组患者的MACCE发生率明显高于非HTPR组(log-rank检验,P=0.01)。Cox多因素分析显示,HTPR是接受复杂PCI治疗的冠心病患者发生MACCE的独立危险因素(HR=2.69,95%CI 1.23~5.85,P=0.01)。PCI术后不同时间DAPT亚组间MACCE发生率差异无统计学意义(P>0.05)。 结论: PFT系列检测能够预测复杂PCI术后患者的临床结局。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li MM, Li Q, Ren XJ, et al. [Predictive value of serial platelet function testing on outcome in patients undergoing complex percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29036975. doi:10.3760/cma.j.issn.0253-3758.2017.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。